Barrington Research Forecasts Lower Earnings for Cinemark

Cinemark Holdings, Inc. (NYSE:CNK) – Barrington Research dropped their Q1 2025 earnings per share (EPS) estimates for shares of Cinemark in a note issued to investors on Monday, March 24th. Barrington Research analyst P. Sholl now expects that the company will post earnings per share of ($0.26) for the quarter, down from their prior forecast of ($0.07). Barrington Research currently has a “Outperform” rating and a $40.00 target price on the stock. The consensus estimate for Cinemark’s current full-year earnings is $1.93 per share. Barrington Research also issued estimates for Cinemark’s Q2 2025 earnings at $0.50 EPS, Q3 2025 earnings at $0.57 EPS, Q4 2025 earnings at $0.44 EPS, Q1 2026 earnings at ($0.07) EPS, Q2 2026 earnings at $0.68 EPS, Q3 2026 earnings at $0.77 EPS and Q4 2026 earnings at $0.52 EPS.

Cinemark (NYSE:CNK) last announced its earnings results on Wednesday, February 19th. The company reported $0.33 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.39 by ($0.06). Cinemark had a net margin of 10.16% and a return on equity of 65.83%. The company had revenue of $814.30 million during the quarter, compared to analyst estimates of $797.18 million. During the same quarter last year, the business earned ($0.15) EPS. The firm’s revenue for the quarter was up 27.5% compared to the same quarter last year.

A number of other brokerages have also issued reports on CNK. Morgan Stanley lowered their price target on Cinemark from $40.00 to $35.00 and set an “overweight” rating on the stock in a research note on Thursday, February 20th. Wells Fargo & Company lowered their target price on shares of Cinemark from $38.00 to $36.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 29th. Wedbush reiterated a “neutral” rating and issued a $32.00 target price on shares of Cinemark in a research report on Tuesday, February 18th. JPMorgan Chase & Co. decreased their price target on shares of Cinemark from $31.00 to $30.00 and set a “neutral” rating on the stock in a research note on Thursday, February 20th. Finally, Macquarie reaffirmed an “outperform” rating and set a $35.00 price objective on shares of Cinemark in a research note on Thursday, February 20th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $32.70.

Cinemark Trading Down 1.3 %

CNK stock opened at $25.71 on Thursday. Cinemark has a 12-month low of $16.32 and a 12-month high of $36.28. The business’s 50-day moving average is $27.62 and its 200 day moving average is $29.42. The company has a current ratio of 1.01, a quick ratio of 0.96 and a debt-to-equity ratio of 3.28. The stock has a market cap of $3.14 billion, a price-to-earnings ratio of 12.67 and a beta of 2.41.

Cinemark Announces Dividend

The firm also recently disclosed a — dividend, which was paid on Wednesday, March 19th. Investors of record on Wednesday, March 5th were given a $0.08 dividend. The ex-dividend date was Wednesday, March 5th. Cinemark’s payout ratio is 15.76%.

Insiders Place Their Bets

In related news, insider Wanda Marie Gierhart sold 9,119 shares of Cinemark stock in a transaction that occurred on Tuesday, February 25th. The shares were sold at an average price of $27.00, for a total value of $246,213.00. Following the completion of the sale, the insider now owns 147,414 shares in the company, valued at approximately $3,980,178. This trade represents a 5.83 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 2.30% of the stock is owned by insiders.

Institutional Investors Weigh In On Cinemark

A number of institutional investors have recently modified their holdings of CNK. Mackenzie Financial Corp acquired a new position in Cinemark in the 4th quarter valued at about $221,000. Elequin Capital LP boosted its stake in shares of Cinemark by 211.6% in the fourth quarter. Elequin Capital LP now owns 997 shares of the company’s stock valued at $31,000 after purchasing an additional 677 shares during the period. PharVision Advisers LLC acquired a new position in shares of Cinemark in the fourth quarter valued at approximately $277,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Cinemark by 24.0% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 319,768 shares of the company’s stock worth $9,906,000 after buying an additional 61,911 shares during the period. Finally, Voloridge Investment Management LLC purchased a new stake in Cinemark during the 4th quarter worth approximately $8,317,000.

Cinemark Company Profile

Cinemark Holdings, Inc, together with its subsidiaries, engages in the motion picture exhibition business. As of February 16, 2024, it operated 501 theatres with 5,719 screens in 42 states and 13 countries in South and Central America. Cinemark Holdings, Inc was founded in 1984 and is headquartered in Plano, Texas.